Factors that influence the decision include: baseline IGF-1 (lower IGF-1 may favor sermorelin to start), metabolic syndrome status (favors tesamorelin), visceral adiposity (favors tesamorelin), prior response to growth hormone-releasing peptides (helps calibrate dose), and patient tolerance preferences
Research Use Information CJC-1295 Ipamorelin 10mg peptide is supplied strictly for laboratory research purposes only
Nurx helps identify what youre experiencing, then connects you with a licensed clinician for personalized treatment
These processes consume time and resources, and they can delay treatment initiation
Cymbiotikas Commitment to Empowerment At Cymbiotika, we believe that wellness starts with trust
Its approved for adults with a BMI of 30 or more, or 27 with weight-related conditions